Association between interleukin 6 gene polymorphisms and Behçet ’ s disease in Korean people
暂无分享,去创建一个
I. Peene | A. Union | L. Meheus | J. Rovensky | P. Aries | F. de Keyser | E. Rovenská | S. Štvrtina | O. Greguska | L. Pravda | I. Hoffman | L. Cebecauer | F. Hulstaert | E. Veys | W. L. Gross | Falk Rj | K. De Bosschere | D. Isenberg | Gross Wl | T. Huizinga | P. Lamprecht | M. Reuter | G. J | Sola J | Ortuño G | Vincente J Mesa-Del-Castillo | Vincente V | Jenette Jc | Andrassy K Bacon | Pa Churg
[1] D A Bloch,et al. The American College of Rheumatology 1990 criteria for the classification of vasculitis. Introduction. , 2010, Arthritis and rheumatism.
[2] David G I Scott,et al. Epidemiology of systemic vasculitis , 2005, Current rheumatology reports.
[3] K. Kim,et al. Endothelial nitric oxide synthase gene polymorphisms in Behçet’s disease and rheumatic diseases with vasculitis , 2003, Annals of the rheumatic diseases.
[4] B. Dijkmans,et al. Early changes in bone metabolism in rheumatoid arthritis patients treated with infliximab. , 2003, Arthritis and rheumatism.
[5] M. Dougados,et al. International ASAS consensus statement for the use of anti-tumour necrosis factor agents in patients with ankylosing spondylitis , 2003, Annals of the rheumatic diseases.
[6] W. Mohr. On the origin of rice bodies with apatite crystals , 2003, Annals of the rheumatic diseases.
[7] J. Braun,et al. Treatment of active ankylosing spondylitis with pamidronate. , 2003, Rheumatology.
[8] Tore K Kvien,et al. Radiographic damage associated with low bone mineral density and vertebral deformities in rheumatoid arthritis: the Oslo-Truro-Amsterdam (OSTRA) collaborative study. , 2003, Arthritis and rheumatism.
[9] A. Dolan,et al. Does active treatment of rheumatoid arthritis limit disease-associated bone loss? , 2002, Rheumatology.
[10] W. Gross,et al. Autoantibodies against granulocyte colony-stimulating factor in Felty's syndrome and neutropenic systemic lupus erythematosus. , 2002, Arthritis and rheumatism.
[11] A. Tenenbaum,et al. Autoantibodies to Cardiolipin and Beta-2-Glycoprotein-I in Coronary Artery Disease Patients with and without Hypertension , 2002, Cardiology.
[12] G. Jhangri,et al. A six-month randomized, controlled, double-blind, dose-response comparison of intravenous pamidronate (60 mg versus 10 mg) in the treatment of nonsteroidal antiinflammatory drug-refractory ankylosing spondylitis. , 2002, Arthritis and rheumatism.
[13] D. Grainger,et al. High titres of serum antinuclear antibodies, mostly directed against nucleolar antigens, are associated with the presence of coronary atherosclerosis , 2002, Annals of the rheumatic diseases.
[14] A. Hamzaoui,et al. Cytokine profile in Behçet's disease patients , 2002, Scandinavian journal of rheumatology.
[15] F. Rigal,et al. Localized polyarteritis nodosa with periostitis. , 2001, The Journal of rheumatology.
[16] A. Tenenbaum,et al. Coronary Artery Disease but Not Coronary Calcification Is Associated with Elevated Levels of Cardiolipin, Beta-2-Glycoprotein-I, and Oxidized LDL Antibodies , 2001, Cardiology.
[17] S. Hancocks. view from the chair: I go to a friend , 2001, British Dental Journal.
[18] X. Marchandise,et al. Factors influencing bone loss in rheumatoid arthritis: a longitudinal study. , 2000, Clinical and experimental rheumatology.
[19] B. Dijkmans,et al. Data driven attempt to create a clinical algorithm for identification of women with rheumatoid arthritis at high risk of osteoporosis , 2000, Annals of the rheumatic diseases.
[20] F. Jessen,et al. Association between an interleukin-6 promoter and 3′ flanking region haplotype and reduced Alzheimer's disease risk in a German population , 2000, Neuroscience Letters.
[21] K. Pile,et al. Evaluation of antibodies to beta2-glycoprotein 1 in the causation of coronary atherosclerosis as part of the antiphospholipid syndrome. , 1999, Australian and New Zealand journal of medicine.
[22] P. Sham,et al. Model-Free Analysis and Permutation Tests for Allelic Associations , 1999, Human Heredity.
[23] C. Korkmaz,et al. Sarcoidosis with palpable nodular myositis, periostitis and large-vessel vasculitis stimulating Takayasu's arteritis. , 1999, Rheumatology.
[24] M. Rogers,et al. Heterocycle‐Containing Bisphosphonates Cause Apoptosis and Inhibit Bone Resorption by Preventing Protein Prenylation: Evidence from Structure‐Activity Relationships in J774 Macrophages , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[25] J S Yudkin,et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. , 1998, The Journal of clinical investigation.
[26] D. Scott,et al. Cutaneous vasculitis in a defined population--clinical and epidemiological associations. , 1998, The Journal of rheumatology.
[27] S. van der Linden,et al. Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis , 1997, The Lancet.
[28] S. Ralston,et al. Polymorphisms of the interleukin-6 gene are associated with bone mineral density , 1997, Osteoporosis International.
[29] J. Rowe,et al. Treatment of the neutropenia of Felty syndrome. , 1996, Blood reviews.
[30] H. Sekihara,et al. Interleukin-6 (IL-6) in patients with Behçet's disease. , 1996, Journal of dermatological science.
[31] D. Scott,et al. Epidemiology of systemic vasculitis: changing incidence or definition? , 1995, Seminars in arthritis and rheumatism.
[32] R J Falk,et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. , 1994, Arthritis and rheumatism.
[33] J. Vicente,et al. Microscopic rice bodies in rheumatoid synovial fluid sediments. , 1992, The Journal of rheumatology.
[34] S. Ralston,et al. Prevalence of vertebral compression fractures due to osteoporosis in ankylosing spondylitis. , 1990, BMJ.
[35] A. Bowcock,et al. Rapid detection and sequencing of alleles in the 3' flanking region of the interleukin-6 gene. , 1989, Nucleic acids research.
[36] K. Kidd,et al. The human "interferon-beta 2/hepatocyte stimulating factor/interleukin-6" gene: DNA polymorphism studies and localization to chromosome 7p21. , 1988, Genomics.
[37] G. Hauck. The connective tissue space in view of the lymphology , 1982, Experientia.
[38] A. Silman,et al. [Criteria of diagnosis of Behcet's disease]. , 1975, La Tunisie medicale.
[39] A. H. Woodward,et al. Periosteal new bone formation in polyarteritis nodosa: a syndrome involving the lower extremities. , 1974, Arthritis and rheumatism.
[40] P. Saville. Polyarteritis nodosa with new bone formation. , 1956, The Journal of bone and joint surgery. British volume.
[41] H. Florey,et al. Proliferation of lymphatics in inflammation , 1937 .
[42] J. G. Kuhns. LYMPHATIC DRAINAGE OF JOINTS , 1933 .
[43] G. Haugeberg,et al. Primary vasculitis in a Norwegian community hospital: A retrospective study , 2005, Clinical Rheumatology.
[44] J. Neumüller,et al. Structure of synovial lymphatic capillaries in rheumatoid arthritis and juvenile idiopathic arthritis. , 2003, International journal of tissue reactions.
[45] M. Karkkainen,et al. Molecular regulation of lymphangiogenesis and targets for tissue oedema. , 2001, Trends in molecular medicine.
[46] A. Collins,et al. The prevalence of vertebral fractures in mild ankylosing spondylitis and their relationship to bone mineral density. , 2000, Rheumatology.
[47] E. Hess,et al. Accelerated atherosclerosis and coronary disease in SLE. , 1997, Lupus.
[48] Y. Shoenfeld,et al. Emerging cross-regulatory roles of immunity and autoimmunity in atherosclerosis , 1996, Immunologic research.
[49] Qingbo Xu,et al. Is atherosclerosis an immunologically mediated disease? , 1995, Immunology today.
[50] B. Haynes,et al. Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. , 1983, Annals of internal medicine.
[51] J. Casley‐Smith. The fine structure of the microvasculature in inflammation. , 1979, Bibliotheca anatomica.